The results from tissues showed that CASC9 was overexpressed in 68% of the tumor specimens relative to normal tissues (Fig. 2B and C), indicating that the upregulation of CASC9 is associated with ESCC development. The gene discussed is CASC9; the disease is esophageal squamous cell carcinoma.